Clinical Trials Logo
  1. Home
  2. Neural Tube Defects
  3. NCT04135274
  4. Details
NCT04135274 Clinical Trial

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?

Neural Tube Defects Clinical Trial

Official title:
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04135274
Other study ID # 2018/12- 7
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2015
Est. completion date December 30, 2018

Study information
Verified date October 2019
Source Tepecik Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

We aimed to investigate whether Neutrophil Lymphocyte Ratio is a Prognostic Factor of Sepsis in Newborns with operated Neural Tube Defects?

Recruitment information / eligibility
Status Completed
Enrollment 57
Est. completion date December 30, 2018
Est. primary completion date December 30, 2018
Accepts healthy volunteers
Gender All
Age group N/A to 28 Days
Eligibility Inclusion Criteria:

- <28 days diagnosed with with neural Tüpe Defects To be operated

Exclusion Criteria:

- >28 days

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Neutrophil to lymphocyte ratio
Neutrophil to lymphocyte ratio

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Tepecik Training and Research Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary Neutrophil to lymphocyte ratio is prognostic faktör for Sepsis 3 years
See also
  Status Clinical Trial Phase
Completed NCT05883761 - Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
Terminated NCT04140669 - Automated Myocardial Performance Index Using Samsung HERA W10
Completed NCT01244399 - Influence of "Espresso" on Adsorption of Myo-inositol
Recruiting NCT04362592 - In-Utero Endoscopic Correction of Spina Bifida N/A
Recruiting NCT03856034 - Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele N/A
Recruiting NCT05672849 - Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases N/A
Active, not recruiting NCT03936322 - Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study N/A
Completed NCT01743196 - Folate Metabolism in Normal Weight and Obese Women of Child-bearing Age N/A
Active, not recruiting NCT03090633 - Fetoscopic Repair of Isolated Fetal Spina Bifida N/A
Completed NCT01392989 - Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders Phase 2
Completed NCT06174883 - Salt-FA to Increase Folate Levels
Completed NCT05935631 - Feasibility, Acceptability and Directional Signal Effect on Blood Folate Levels of Iodized Salt Fortified With Folic Acid: Clinical Study N/A
Recruiting NCT03315637 - Fetal Endoscopic Surgery for Spina Bifida N/A
Completed NCT00394862 - Efficacy of Weekly Versus Daily Folic Acid Supplementation N/A
Completed NCT06135883 - Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects
Active, not recruiting NCT04760509 - Short- Term Follow up Of Neonates Born With Neural Tube Defect
Active, not recruiting NCT03794011 - Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study Phase 1
Recruiting NCT04523233 - Metals/Vitamins Levels in NTD
Recruiting NCT01253746 - Genetics of Neural Tube Defects N/A
Completed NCT00468481 - Efficacy and Safety Study for an Oral Contraceptive Containing Folate Phase 3